PM2.5 Exposure, Obesity, and Cardiovascular Health
Investigating Interactions Between PM2.5 Exposure, Obesity, Cardiovascular Health and Dietary Antioxidant in Subjects With Obesity
Obesity and exposure to fine particulate matter (particles of aerodynamic diameter less than 2.5 µm, PM2.5) air pollution are established risk factors for cardiovascular (CV) morbidity and mortality. This proposed pilot project seeks to assess interactions between PM2.5 exposure, obesity, CV health, and dietary antioxidant in subjects with obesity.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
This proposed intervention study will investigate (1) whether the use of portable air filtration systems (PAFS), by lowering PM2.5 exposures, will improve CV risk factors in subjects with obesity; and (2) whether antioxidant levels will modify the association between PM2.5 exposure and blood pressure. Our project will help validate the benefits of novel strategies to employ PAFS. Positive results would represent a key step in forming the evidence base required to promote more wide-scale PAFS use; in the long term, given their low cost and burden, PAFS use could be up-scaled to help protect diverse populations.
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Michigan
-
East Lansing, Michigan, Forenede Stater, 48824
- Rekruttering
- Michigan State University
-
Kontakt:
- Study coordinator
- Telefonnummer: 517-884-4068
- E-mail: klaverza@msu.edu
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- ≥21 years old
- diagnosis of hypertension (BP ≥140/90 mm Hg)
- obesity (BMI>30)
Exclusion Criteria:
- any CV event (myocardial infarction, stroke, heart failure) in the past 3 months
- unstable CV condition (class 3-4 angina or heart failure) or any medical condition that would place the subject at risk from participation or jeopardize study integrity (per investigators)
- expected overnight travel outside their home during the 9-week study period
- unable to comprehend/sign informed consent
- lung disease requiring oxygen
- cancer receiving active treatment or chemotherapy
- CPAP use for sleep apnea
- CV medication change in the prior month
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Grundvidenskab
- Tildeling: Randomiseret
- Interventionel model: Crossover opgave
- Maskning: Dobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Sham-komparator: Arm 1
Participants are exposed to unfiltered air (sham) via air filtration systems in the bedroom and main living space of each residence. |
Subjects were exposed to high-efficiency filtered air. |
|
Aktiv komparator: Arm 2
Participants were exposed to high-efficiency (HEPA) filtered air via air filtration systems in the bedroom and main living space of each residence. |
Subjects were exposed to high-efficiency filtered air. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Brachial blood pressure
Tidsramme: Daily for 28 days, between 8-10 AM, starting 24 hours after air filtration systems are placed
|
Daily for 28 days, between 8-10 AM, starting 24 hours after air filtration systems are placed
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
C-reactive protein
Tidsramme: Day 1 and Day 28 of each 4-week intervention period.
|
Blood samples for inflammatory marker (high-sensitivity C-reactive protein) |
Day 1 and Day 28 of each 4-week intervention period.
|
|
Carotenoid
Tidsramme: Day 1 and Day 28 of each 4-week intervention period.
|
non-invasive optical measurement of skin carotenoid levels |
Day 1 and Day 28 of each 4-week intervention period.
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- CH-MSU Alliance
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .